Cargando…

Editorial: Anesthesia and cancer: Friend or foe?

Detalles Bibliográficos
Autores principales:	Bezu, Lucillia, Díaz-Cambronero, Oscar, Kepp, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807074/ https://www.ncbi.nlm.nih.gov/pubmed/36601470 http://dx.doi.org/10.3389/fonc.2022.1095800

Ejemplares similares

Impact of local anesthetics on epigenetics in cancer
por: Bezu, Lucillia, et al.
Publicado: (2022)

Anesthesia and Oncology: Friend or Foe?
por: Buddeberg, Bigna S., et al.
Publicado: (2022)

Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer
por: Wu Chuang, Alejandra, et al.
Publicado: (2022)

Anesthesia and Cancer, Friend or Foe? A Narrative Review
por: Montejano, Julio, et al.
Publicado: (2021)

Oral microbiota in oropharyngeal cancers: Friend or foe?
por: Nocini, Riccardo, et al.
Publicado: (2022)

ARID1A in cancer: Friend or foe?
por: Fontana, Beatrice, et al.
Publicado: (2023)

Malignancy and IFITM3: Friend or Foe?
por: Rajapaksa, Ushani S., et al.
Publicado: (2020)

The Role of SETBP1 in Gastric Cancer: Friend or Foe
por: Fang, Fujin, et al.
Publicado: (2022)

Immune System, Friend or Foe of Oncolytic Virotherapy?
por: Filley, Anna C., et al.
Publicado: (2017)

The RNA-Binding Motif Protein Family in Cancer: Friend or Foe?
por: Li, Zhigang, et al.
Publicado: (2021)

Epidural anesthesia during surgery: friend or foe?
por: Koepfli, E, et al.
Publicado: (2009)

Immunological Effects of Epigenetic Modifiers
por: Bezu, Lucillia, et al.
Publicado: (2019)

Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?
por: Kosaka, Takeo, et al.
Publicado: (2014)

The Two Sides of YY1 in Cancer: A Friend and a Foe
por: Sarvagalla, Sailu, et al.
Publicado: (2019)

Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022)

Editorial: Function and Flexibility: Friend or Foe?
por: Pauwels, Kris, et al.
Publicado: (2016)

Editorial: Chocolate and Health: Friend or Foe?
por: Serafini, Mauro, et al.
Publicado: (2017)

Therapy-Induced Tumor Cell Death: Friend or Foe of Immunotherapy?
por: van Schaik, Thijs A., et al.
Publicado: (2021)

Editorial: Innate Lymphoid Cells in Cancer: Friends or Foes?
por: Jacquelot, Nicolas, et al.
Publicado: (2021)

Editorial: Ultraviolet Radiation: Friend or Foe for Plants?
por: Llorens, Laura, et al.
Publicado: (2020)

Editorial: Synaptic plasticity and dysfunction, friend or foe?
por: Nugent, Fereshteh S., et al.
Publicado: (2023)

Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma
por: Zhou, Liang
Publicado: (2022)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Etomidate for anesthesia induction: friends or foe in major cardiac surgery?
por: De Jong, Audrey, et al.
Publicado: (2014)

Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
por: Yuan, Qingchen, et al.
Publicado: (2020)

RCC Immune Microenvironment Subsequent to Targeted Therapy: A Friend or a Foe?
por: Chen, Wenjin, et al.
Publicado: (2020)

Friend and Foe
Publicado: (1890)

Editorial: NK Cells in Human Diseases: Friends or Foes?
por: Vieillard, Vincent, et al.
Publicado: (2017)

Editorial: TGF-β in Human Disease: Friend or Foe?
por: Zheng, Guoping, et al.
Publicado: (2021)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

Chemokines and Cancer: Friends or Foes?
por: Strazza, Marianne, et al.
Publicado: (2020)

Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021)

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
por: Pacelli, Paola, et al.
Publicado: (2022)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_mpiktrd0j8rq6g333lagrqeldn